Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,250 | 14,480 | 17,289 | 26,884 | 21,383 |
| TOTAL | $14,271 | $18,251 | $20,693 | $29,600 | $24,051 |
| Non-Current Assets | |||||
| PPE Net | 84 | 45 | 51 | 58 | 65 |
| Other Non-Current Assets | 92 | 211 | 45 | 59 | 72 |
| TOTAL | $176 | $256 | $96 | $117 | $137 |
| Total Assets | $14,447 | $18,507 | $20,789 | $29,717 | $24,188 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,444 | 1,263 | 2,982 | 1,605 | 1,338 |
| Accrued Expenses | 1,762 | 1,571 | 1,706 | 3,136 | 2,809 |
| TOTAL | $3,224 | $2,870 | $4,741 | $4,810 | $4,202 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 18 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $18 |
| Total Liabilities | $3,224 | $2,870 | $4,741 | $4,810 | $4,220 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,013 | 2,874 | 2,650 | 2,650 | 2,554 |
| Common Shares | 30 | 1,211 | 1,194 | 27 | 887 |
| Retained earnings | -161,942 | -155,924 | -154,777 | -145,367 | -139,300 |
| TOTAL | $11,223 | $15,637 | $16,048 | $24,907 | $19,968 |
| Total Liabilities And Equity | $14,447 | $18,507 | $20,789 | $29,717 | $24,188 |